Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TianTi Biotherapeutics

Request full access

Next-gen biotech developing therapeutic antibodies using proprietary single cell microfluidics and yeast display systems

Suzhou Shi, ChinaFounded 2021Biotech & Life Sciences

About TianTi Biotherapeutics

TianTi Biotherapeutics is a preclinical stage biotech company specializing in the development of therapeutic antibodies. The company leverages proprietary single cell microfluidics and yeast display systems to fundamentally change the way antibodies are made. TianTi Bio focuses on oncology and rare disease indications, aiming to deliver fast, high-quality results for challenging targets. By combining rigorous data analysis and teamwork, the company generates a greater number of differentiated antibodies, providing a strong basis for intellectual property protection. TianTi Biotherapeutics operates labs in Greater Boston, MA, and Suzhou, China, and collaborates with multidisciplinary teams and industry partners to pioneer visionary new medicines globally. The business model revolves around preclinical research and development, targeting pharmaceutical companies and research institutions as primary clients. Revenue is generated through partnerships, licensing agreements, and potential future product sales.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Microfluidics, Disease, Biotech and Pharma, DT and LS, science-based
Technology
Artificial Intelligence
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2021 $14M $55M Oriza Holdings · Yuexiu Industrial Fund · Shanghai Biomedical Innovation and Transformation Fund · Kaitai Capital ↗
OtherOther financing May 2021 $0 — Cathay Capital ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

TianTi Biotherapeutics website traffic

Latest recorded traffic for TianTi Biotherapeutics is 350 monthly website visits, up 1066.7% over the last three months.

Latest monthly visits350 3-month web change+1066.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

TianTi Biotherapeutics in the Suzhou Shi ecosystem

Live from Dealroom

The TianTi Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Oriza Holdings
  • Yuexiu Industrial Fund
  • Shanghai Biomedical Innovation and Transformation Fund
  • Kaitai Capital

Other known investors1 additional known investor

  • Cathay Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Suzhou Shi HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TianTi Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TianTi Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.